NKTR Movantik revenue is reduced a bit to support advertising and the REMS database. Plus/minus a few million of Movantik royalties is less important than plus/minus tens millions in NKTR's estimate of cash on hand at the end of 2016. The estimate was $200M at the last CC.
I've asked this before and haven't seen any responses. Has anyone checked their personal health insurance drug coverage to see what tier Movantik is on? It's still tier 3 on mine. AZN is supposed to be making a push for tier 2, anyone seen results?